Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
21 studies found for:    Dimebon Alzheimer's
Show Display Options
Rank Status Study
21 Completed
Has Results
A Study To Evaluate The Abuse Potential Of Single Oral Doses Of Dimebon (Latrepirdine) In Healthy Recreational Polydrug Users
Conditions: Alzheimer's Disease;   Huntington's Disease
Interventions: Drug: dimebon;   Drug: placebo;   Drug: alprazolam

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-21) Next Page   
Study has passed its completion date and status has not been verified in more than two years.